Literature DB >> 16061427

Tetrahydrocurcumin in plasma and urine: quantitation by high performance liquid chromatography.

Dennis D Heath1, Milagros A Pruitt, Dean E Brenner, Aynun N Begum, Sally A Frautschy, Cheryl L Rock.   

Abstract

Tetrahydrocurcumin (THC), one of the major metabolites of curcumin, exhibits many of the same physiologic and pharmacological activities as curcumin and in some systems may exert greater antioxidant activity than curcumin. However, evaluation of clinical efficacy is limited by lack of sensitive methods for quantifying intake/absorption in blood or urine. We have developed a sensitive high performance liquid chromatography (HPLC) analytical method for detection of THC in plasma and urine. The method involves extracting the THC from 0.2 mL samples with 95% ethyl acetate/5% methanol, and beta-17-estradiol acetate as an internal standard. Analysis with a reversed-phase C18 column and UV detection at 280 nm demonstrates linear performance from 0.050 to 6.0 microg/mL in plasma, and 0.060 to 6.0 microg/mL in urine. The coefficients of variation for intra- and inter-assays were each<8.6%. The average recovery of THC from plasma and urine was greater than 98.5%. These data demonstrate a rapid, sensitive and accurate method for HPLC quantification of THC in plasma and urine.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16061427     DOI: 10.1016/j.jchromb.2005.07.026

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  5 in total

1.  Lack of efficacy of curcumin on neurodegeneration in the mouse model of Niemann-Pick C1.

Authors:  Ivan A Borbon; Zach Hillman; Ernesto Duran; Pawel R Kiela; Sally A Frautschy; Robert P Erickson
Journal:  Pharmacol Biochem Behav       Date:  2011-12-17       Impact factor: 3.533

2.  Tetrahydrocurcumin-loaded vaginal nanomicrobicide for prophylaxis of HIV/AIDS: in silico study, formulation development, and in vitro evaluation.

Authors:  Amit Mirani; Harish Kundaikar; Shilpa Velhal; Vainav Patel; Atmaram Bandivdekar; Mariam Degani; Vandana Patravale
Journal:  Drug Deliv Transl Res       Date:  2019-08       Impact factor: 4.617

3.  Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer's disease.

Authors:  Aynun N Begum; Mychica R Jones; Giselle P Lim; Takashi Morihara; Peter Kim; Dennis D Heath; Cheryl L Rock; Mila A Pruitt; Fusheng Yang; Beverly Hudspeth; Shuxin Hu; Kym F Faull; Bruce Teter; Greg M Cole; Sally A Frautschy
Journal:  J Pharmacol Exp Ther       Date:  2008-04-16       Impact factor: 4.030

4.  Tetrahydrocurcumin induces mesenchymal-epithelial transition and suppresses angiogenesis by targeting HIF-1α and autophagy in human osteosarcoma.

Authors:  Yan Zhang; Ying Liu; Jilong Zou; Lixin Yan; Wei Du; Yafeng Zhang; Hanliang Sun; Peng Lu; Shuo Geng; Rui Gu; Hongyue Zhang; Zhenggang Bi
Journal:  Oncotarget       Date:  2017-08-03

5.  Development of a validated UPLC-qTOF-MS Method for the determination of curcuminoids and their pharmacokinetic study in mice.

Authors:  Mahendra K Verma; Ishtiyaq A Najar; Manoj K Tikoo; Gurdarshan Singh; Devinder K Gupta; Rajneesh Anand; Ravi K Khajuria; Subhash C Sharma; Rakesh K Johri
Journal:  Daru       Date:  2013-01-29       Impact factor: 3.117

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.